Prostate cancer decisions — 2024

The Board denied the Veteran's claims for service connection for prostate cancer and its residuals, finding that there is no causal relationship between in-service prostatitis and the current condition.

The Veteran's claim for TDIU due to service-connected disabilities, including prostate cancer and related conditions, is remanded as the Board found a pre-decisional duty to assist error. The case requires further examination to assess the impact of these conditions on employment.

The Veteran's service records confirm his exposure to toxic herbicides while stationed in Thailand, leading to the grant of service connection for prostate cancer on a direct basis from September 30, 2021.

The Board has granted service connection for prostate cancer, colon cancer, skin cancer, and COPD disabilities based on the Veteran's in-service exposure to asbestos and toxic gasses.

The Veteran's TDIU claim is dismissed as moot because he is already receiving a total disability rating and SMC benefits under 38 U.S.C. § 1114(s). The Board also granted SMC based on housebound status due to service-connected PTSD and major depressive disorder.

The Veteran's initial compensable rating for hypertension from August 10, 2022, to May 8, 2023, was denied. The discontinuance of the 100 percent rating for residuals of prostate cancer effective August 1, 2023, was upheld.

The Board has granted service connection for prostate cancer, colon cancer, skin cancer, and COPD disabilities based on the Veteran's in-service exposure to asbestos and toxic gasses.

The Veteran's service-connected conditions, including PTSD and prostate cancer residuals, rendered him unable to secure and follow a substantially gainful occupation.

The Veteran's prostate cancer is related to his in-service exposure to contaminated water at Camp Lejeune, and the Board has granted service connection for this condition.

The Veteran's appeals for increased ratings for PTSD, prostate cancer residuals, and hypertension have been dismissed as the March 2024 Board decision implementing these determinations is considered a purely ministerial implementation of prior decisions.,An initial evaluation in excess of 10 percent for hypertension has not been granted due to the Veteran's blood pressure readings consistently being below the threshold required for higher ratings under Diagnostic Code 7101.

The Board has decided to remand the case due to a lack of an opinion regarding whether the Veteran's prostate cancer is related to exposure to contaminated water at Camp Lejeune. The claim will be reconsidered with the addition of a new medical opinion.

The Board denied the Veteran's claim for an earlier effective date for SMC based on aid and attendance, finding that he did not require regular aid and attendance due to his service-connected disabilities prior to March 12, 2014.

The Board has granted service connection for prostate cancer, finding that the Veteran was exposed to herbicide agents during his service in Korea and thus meets the presumptive exposure criteria.

The Board has decided to remand the case due to insufficient evidence regarding the Veteran's prostate cancer and its relation to his active duty service, specifically any exposure to contaminated water.

The Board has granted service connection for prostate cancer, colon cancer, skin cancer, and COPD disabilities based on the Veteran's in-service exposure to toxic gasses and asbestos.

The Board has granted service connection for prostate cancer, colon cancer, skin cancer, and COPD disabilities based on the Veteran's in-service exposure to toxic gasses and asbestos.

The Board has granted service connection for prostate cancer, colon cancer, skin cancer, and COPD disabilities based on the Veteran's in-service exposure to asbestos and toxic gasses.

The Board has granted an effective date of September 23, 2020 for the grant of service connection for tinnitus. The Veteran's claim for earlier effective dates and increased ratings are addressed in separate sections.

The Veteran's claim for a higher rating for prostate cancer residuals was denied, and his request to restore special monthly compensation based on housebound criteria was dismissed.

The Veteran's prostate cancer and related residuals are granted as service-connected under the PACT Act, effective August 2022. The issue of tinnitus is remanded for further development.